Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

  • N. Plevris (Lead / Corresponding author)
  • , C. S. Chuah
  • , R. M. Allen
  • , I. D. Arnott
  • , P. N. Brennan
  • , S. Chaudhary
  • , A. M. D. Churchhouse
  • , S. Din
  • , E. Donoghue
  • , Daniel R. Gaya
  • , M. Groome
  • , H. M. Jafferbhoy
  • , P. W. Jenkinson
  • , W. L. Lam
  • , M. Lyons
  • , J. C. Macdonald
  • , M. MacMaster
  • , C. Mowat
  • , G. D. Naismith
  • , L. F. Potts
    • E. Saffouri, J. P. Seenan, A. Sengupta, P. Shasi, D. I. Sutherland, J. A. Todd, J. Veryan, A. J. M. Watson, David Watts, G. R. Jones, C. W. Lees

    Research output: Contribution to journal › Article › peer-review

    46   Link opens in a new tab Citations (Scopus)
    437 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science